Biogen Closes Acquisition of RayThera
Biogen completes the acquisition of RayThera Inc., adding a phase 1 lead program to strengthen its pipeline and advance innovative therapeutic development.
RayThera | 07/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy